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Metabotropic GABAB receptors play a fundamental
role in modulating the excitability of neurons and
circuits throughout the brain. These receptors influ-
ence synaptic transmission by inhibiting presynaptic
release or activating postsynaptic potassium chan-
nels. However, their ability to directly influence dif-
ferent types of postsynaptic glutamate receptors
remains unresolved. Here we examine GABAB recep-
tor modulation in layer 2/3 pyramidal neurons from
the mouse prefrontal cortex. We use two-photon
laser-scanning microscopy to study synaptic mod-
ulation at individual dendritic spines. Using two-
photon optical quantal analysis, we first demonstrate
robust presynaptic modulation of multivesicular
release at single synapses. Using two-photon gluta-
mate uncaging, we then reveal that GABAB receptors
strongly inhibit NMDA receptor calcium signals. This
postsynaptic modulation occurs via the PKA path-
way and does not affect synaptic currents mediated
by AMPA or NMDA receptors. This form of GABAB
receptor modulation has widespread implications
for the control of calcium-dependent neuronal
function.
INTRODUCTION
GABA is the major inhibitory neurotransmitter in the cortex
and signals via both ionotropic and metabotropic receptors
(Sivilotti and Nistri, 1991). GABAB receptors (GABAB-Rs) are G
protein-coupled receptors that release both Ga i/o and Gbg
when activated (Bettler et al., 2004; Mott and Lewis, 1994).
These signaling molecules influence many downstream targets,
including inwardly rectifying potassium (K) channels, voltage-
sensitive calcium (Ca) channels, and adenylyl cyclase (AC)
(Misgeld et al., 1995). GABAB-Rs are important for higher cogni-
tive processes, including multiple forms of learning and memory
(Bowery et al., 2002). They are also therapeutic targets for many
neuropsychiatric disorders, including schizophrenia, addiction,
anxiety, depression, and epilepsy (Bettler et al., 1998).
Throughout the brain, GABAB-Rs regulate synaptic transmis-
sion by either inhibiting neurotransmitter release or dampening
postsynaptic excitability. Presynaptic GABAB-Rs inhibit releaseby modulating Ca channels or interacting with the downstream
release machinery (Dittman and Regehr, 1996; Pfrieger et al.,
1994; Sakaba and Neher, 2003; Scanziani et al., 1992; Takahashi
et al., 1998; Wu and Saggau, 1995). While autoreceptors control
release of GABA itself, heteroreceptors regulate the release of
other neurotransmitters, including glutamate at excitatory syn-
apses (Dittman and Regehr, 1997; Isaacson et al., 1993). The
presence of robust presynaptic modulation at excitatory syn-
apses often makes it difficult to distinguish concurrent postsyn-
aptic effects of GABAB-Rs.
Postsynaptic GABAB-Rs are often located in and near den-
dritic spines, making them well-positioned to influence gluta-
mate receptors (Kulik et al., 2003). Both AMPA receptors
(AMPA-Rs) and NMDA receptors (NMDA-Rs) are molecular tar-
gets of multiple intracellular signaling cascades that can strongly
influence their function (Dingledine et al., 1999; Hollmann and
Heinemann, 1994). For example, protein kinase A (PKA) can
regulate postsynaptic currents and Ca signals mediated by
NMDA-Rs (Greengard et al., 1991; Raman et al., 1996; Skeberdis
et al., 2006). However, despite signaling via Ga i/o to inhibit AC
and reduce cAMP levels (Kaupmann et al., 1997; Knight and
Bowery, 1996; Wojcik and Neff, 1984), previous results suggest
minimal direct modulation of postsynaptic glutamate receptors
by GABAB-Rs.
Instead, GABAB-Rs primarily dampen postsynaptic excit-
ability by releasing Gbg subunits to activate inwardly rectifying
K channels (Ga¨hwiler and Brown, 1985; Lu¨scher et al., 1997;
Sodickson and Bean, 1996). Opening these channels generates
local shunting and slow inhibitory postsynaptic potentials
(IPSPs) (Alger, 1984; Benardo, 1994; Dutar and Nicoll, 1988;
Newberry and Nicoll, 1984; Tama´s et al., 2003). These GABAB-
R IPSPs can enhance magnesium (Mg) block of NMDA-Rs to
indirectly inhibit synaptic responses (Morrisett et al., 1991;
Otmakhova and Lisman, 2004). In addition to the inhibition of
voltage-sensitive Ca channels (VSCCs) (Mintz and Bean, 1993;
Pe´rez-Garci et al., 2006; Sabatini and Svoboda, 2000; Scholz
and Miller, 1991), this indirect block of NMDA-Rs is thought to
be an important mechanism by which GABAB-Rs influence Ca
signals in dendrites and spines.
Here we examine themechanisms bywhichGABAB-Rsmodu-
late excitatory inputs onto layer 2/3 pyramidal neurons in the
mouse prefrontal cortex (PFC). Our experiments combine two-
photon laser-scanning microscopy (2PLSM) with two-photon
laser uncaging (2PLU) of glutamate to determine the presynaptic
and postsynaptic influences of GABAB-Rs at single spines. Two-
photon optical quantal analysis reveals that presynaptic GABAB-
Rs reduce multivesicular release at individual synapses. InNeuron 66, 101–113, April 15, 2010 ª2010 Elsevier Inc. 101
Figure 1. Modulation of Synaptic Transmission
(A) 2PLSM image of a layer 2/3 pyramidal neuron, overlaid
on an IR-DIC image of the cortical slice, showing recording
(black) and theta-glass stimulating (red) pipettes.
(B) Paired-pulse stimulation (arrows, 50 ms interstimulus
interval) evokes EPSCs mediated by AMPA-Rs at70 mV
(top) or NMDA-Rs at +40 mV (bottom) in baseline con-
ditions (red) and following wash-in of 5 mM baclofen
(black). The dotted gray line shows the baclofen traces
scaled to the first EPSC amplitude in baseline conditions.
Stimulus artifacts have been removed for clarity.
(C) Summary of the effect of 5 mM baclofen on the ampli-
tude of the first AMPA-R andNMDA-REPSCs. For nonnor-
malized data (top), scatter plots show baseline conditions
(base) and conditions after wash-in of 5 mMbaclofen (bac),
where red circles connected by a line are individual exper-
iments before and after baclofen wash-in, and black
circles are the averages. For normalized data (bottom),
red circles indicate individual experiments and box plots
show median, interquartile range, and 10%–90% range.
(D) Summary of the effect of 5 mM baclofen on the paired-
pulse ratio (PPR) of AMPA-R and NMDA-R EPSCs.
Asterisks indicate significant (p < 0.05) difference from
100%.
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GABAB-R Modulation of NMDA-R Ca Signalsaddition, 2PLU demonstrates that postsynaptic GABAB-Rs
directly modulate NMDA-Rs via the PKA pathway. This effect
is specific for NMDA-R Ca signals, with little impact on synaptic
currents mediated by either AMPA-Rs or NMDA-Rs. These
results demonstrate a role for GABAB-Rs in modulating postsyn-
aptic Ca signaling in cortical pyramidal neurons. Given the
importance of NMDA-R Ca signals for synaptic plasticity, spine
morphology, local excitability, and disease, these results have
widespread functional consequences.
RESULTS
Modulation of Synaptic Transmission
We assessed the influence of GABAB-R activation on glutama-
tergic synaptic transmission in the dendrites of layer 2/3 pyra-
midal neurons in acute prefrontal cortical slices. In our initial
experiments, we used 2PLSM and laser-scanning DIC (LS-DIC)102 Neuron 66, 101–113, April 15, 2010 ª2010 Elsevier Inc.to position a theta-glass extracellular stimulus
electrode near the basal dendrites, where
most synaptic inputs are received (Larkman,
1991) (Figure 1A). In neurons held at 70 mV,
local stimulation evoked fast AMPA-R excit-
atory postsynaptic currents (EPSCs) in the
presence of 10 mM CPP to block NMDA-Rs
(Figure 1B). These AMPA-R EPSCs were sup-
pressed by bath application of the GABAB-R
agonist baclofen (5 mM) (19% ± 3% of baseline,
n = 18 cells, p < 0.01) (Figure 1C). Similar stimu-
lation in neurons held at +40 mV evoked
slow NMDA-R EPSCs in the presence of 10 mM
NBQX to block AMPA-Rs (Figure 1B). These
NMDA-R EPSCs were also suppressed by
wash-in of 5 mM baclofen (23% ± 4% of base-
line, n = 11 cells, p < 0.01) (Figure 1C). Theseresults indicate that GABAB-Rs modulate synaptic transmission
at these neurons, which could occur via presynaptic or postsyn-
aptic mechanisms.
We found that both AMPA-R and NMDA-R EPSCs undergo
paired-pulse facilitation (PPF) at these synapses (Figure 1B).
This form of short-term synaptic plasticity is often used as an
indicator of changes in presynaptic probability of release (Pr).
Bath application of 5 mM baclofen enhanced PPF of both
AMPA-R (125% ± 7% of baseline, n = 18 cells, p < 0.05) and
NMDA-R (124% ± 6% of baseline, n = 11 cells, p < 0.01) EPSCs
(Figure 1D). These results suggest that GABAB-Rs act presynap-
tically to suppress glutamate release, but do not exclude addi-
tional effects on postsynaptic glutamate receptors.
Single-Synapse Modulation
We began to distinguish the presynaptic and postsynaptic
effects of GABAB-Rs using two-photon optical quantal analysis
Figure 2. Modulation at Single Spines
(A) (Left) 2PLSM image of a dendrite (D) and two
spines (S1 and S2), with dashed yellow line indi-
cating line scan position, overlaid on an LS-DIC
image showing the theta-glass stimulating pipette
(star). (Right) During a 500 Hz line scan through
dendrite and spines, extracellular stimulation
(arrow) evokes a green Ca transient only in S1
(top), quantified as DG/Gsat (bottom) in baseline
conditions (red) and following wash-in of CPP
(black).
(B) (Left) Stochastic NMDA-R Ca signals in base-
line conditions (red) and following wash-in of 5
mM baclofen (black), where solid and dashed
blue lines indicate mean successes and failures,
respectively. (Right) Time course of NMDA-R Ca
signal amplitudes, where red dots are individual
trials, the dashed black line is the calculated
threshold, and the shaded region includes failures.
For all time courses, the break in the x axis indi-
cates the baclofen wash-in period (5 min) that
occurs between 5 min of baseline acquisition
and 5 min of baclofen acquisition.
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GABAB-R Modulation of NMDA-R Ca Signals(Higley et al., 2009; Mainen et al., 1999; Oertner et al., 2002).
2PLSM and LS-DIC allowed us to position an extracellular stim-
ulus electrode near a targeted spine in the proximal basal
dendrites (Figure 2A). We found that stimulating with theta-glass
pipettes (1–4 mm tip diameter) provided particularly high spatial
resolution and allowed us to reliably select individual spines.
In neurons held at +10 mV and in the presence of NBQX to block
AMPA-Rs (see Experimental Procedures), local stimulation
evoked slow Ca signals in spines, which were completely
blocked by wash-in of 10 mM CPP (0% ± 1% of baseline, n = 4
cells, 4 spines, p < 0.05). These NMDA-R Ca signals are
similar to those observed in other brain regions, and reflect the
release and binding of glutamate from an adjacent presynaptic
terminal.
The stochastic nature of synaptic transmission means that
some trials show clear successes, and others, failures (Fig-
ure 2B) (Mainen et al., 1999). We measured the Pr at individual
spines as the ratio of successes to total stimulus trials, which
was 0.80 ± 0.1 (n = 15 spines) in these recording conditions.
We also measured the synaptic potency at individual spines
as the amplitude of the successful events (see Experimental
Procedures), which was 0.19 ± 0.02 DG/Gsat (n = 15 spines).
Measuring changes in Pr and synaptic potency has previously
been used to distinguish effects on presynaptic glutamate
release and postsynaptic receptor activation by different
modulators at other synapses (Higley et al., 2009; Oertner
et al., 2002).
Having obtained stable baseline responses, we tested for the
effects of GABAB-R modulation by washing baclofen into the
bath (Figure 2B). We found that 5 mM baclofen nearly eliminated
the NMDA-R Ca signal by dramatically reducing the Pr (5% ± 6%of baseline, n = 5 cells, 5 spines, p < 0.01), indicating powerful
GABAB-R modulation at the level of single synapses. However,
the absence of successful events after 5 mM baclofen prevented
us from separating presynaptic and postsynaptic influences in
these experiments.
In order to distinguish between these influences, we reduced
the level of GABAB-R modulation by using a lower concentra-
tion of baclofen. We also performed parallel experiments with
wash-in of ACSF alone, in order to control for any rundown
of synaptic transmission. We found that bath application of
1 mM baclofen influenced release to a degree that allowed us
to perform two-photon optical quantal analysis (Figure 3A).
As expected, 1 mM baclofen decreased the Pr, consistent
with a presynaptic effect (57% ± 13% of baseline, n = 10 cells,
10 spines, p < 0.01; ACSF: 95% ± 8% of baseline, n = 5 cells,
5 spines, p > 0.05; ACSF versus baclofen, p < 0.01) (Figure 3B).
However, 1 mM baclofen also decreased the synaptic potency,
suggesting a postsynaptic influence (59% ± 7% of baseline,
n = 10 cells, 10 spines, p < 0.01; ACSF: 81% ± 10% of base-
line, n = 5 cells, 5 spines, p > 0.05; ACSF versus baclofen,
p < 0.05) (Figure 3C). Together, these results suggest that
GABAB-R modulation may occur at both presynaptic and post-
synaptic targets.
Presynaptic Modulation
Even when using two-photon optical quantal analysis, distin-
guishing between changes in presynaptic release and postsyn-
aptic receptor activation can be difficult. For example, multive-
sicular release can generate graded postsynaptic responses
(Foster et al., 2005; Tong and Jahr, 1994; Wadiche and Jahr,
2001), such that changes in Pr can appear as changes in synapticNeuron 66, 101–113, April 15, 2010 ª2010 Elsevier Inc. 103
Figure 3. Two-Photon Optical Quantal
Analysis
(A) (Left) Extracellularly evoked NMDA-R Ca
signals in baseline conditions (red) and following
wash-in of 1 mM baclofen (black). (Right) Time
course (top) of NMDA-R Ca signal amplitudes,
where red dots are individual trials, the dashed
black line is the calculated threshold, and the
shaded region includes failures. Frequency histo-
gram (bottom) of DG/Gsat signal amplitudes in
baseline conditions (red) and following 1 mM
baclofen (black) is shown, where the shaded
regions include failures.
(B) (Left) Average time course of probability of
release, calculated using a five-point running
window. Blue lines indicate average periods in
baseline conditions and baclofen. (Right) Sum-
mary of changes in probability of release following
wash-in of baclofen or ACSF.
(C) (Left) Average time course of synaptic potency.
The running average was calculated using a five-
point window and is shown as a black line. Blue
lines indicate average periods in baseline condi-
tions and baclofen. (Right) Summary of changes
in synaptic potency following wash-in of baclofen
or ACSF.
Asterisks indicate significant (p < 0.05) difference
from 100% or between different conditions.
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GABAB-R Modulation of NMDA-R Ca Signalspotency (Higley et al., 2009; Oertner et al., 2002). We next tested
whether this presynaptic effect contributes to the observed
changes in synaptic potency at these synapses.
GABAB-Rs are metabotropic receptors and modulation
involves G protein-coupled signaling cascades (Bettler et al.,
2004; Mott and Lewis, 1994). Therefore, including the nonhydro-
lyzable GDP analog Guanosine-50-[b-thio]diphosphate (GDP-
bS) in the recording pipette should eliminate postsynaptic
modulation, allowing us to isolate presynaptic effects.
We repeated the two-photon optical quantal experiments with
3 mM GDP-bS in the recording pipette, but found that 1 mM
baclofen caused similar modulation of Pr (55% ± 9% of baseline,
n = 10 cells, 10 spines, p < 0.01; ACSF: 107% ± 9% of baseline,
n = 7 cells, 7 spines, p > 0.05; ACSF versus baclofen, p < 0.01)104 Neuron 66, 101–113, April 15, 2010 ª2010 Elsevier Inc.and synaptic potency (56% ± 8% of
baseline, n = 10 cells, 10 spines, p <
0.05; ACSF: 84% ± 7% of baseline,
n = 7 cells, 7 spines, p > 0.05; ACSF
versus baclofen, p < 0.05) (Figures 4A
and 4C). These results suggest a reduc-
tion in multivesicular release may indeed
contribute to the observed changes in
synaptic potency.
Switching from normal (2 mM) to low
(1 mM) extracellular Ca reduces the Pr
to 0.30 ± 0.05 (n = 14 spines) and should
therefore reduce multivesicular release
(Foster et al., 2005; Wadiche and Jahr,
2001). When we repeated these experi-
ments in 1 mM Ca, we found that 1 mMbaclofen continued to decrease the Pr (42% ± 10% of baseline,
n = 8 cells, 8 spines, p < 0.01; ACSF: 98% ± 12% of baseline,
n = 6 cells, 6 spines, p > 0.05; ACSF versus baclofen, p < 0.05),
but no longer significantly decreased the synaptic potency
(90% ± 19% of baseline, n = 8 cells, 8 spines, p > 0.05; ACSF:
110% ± 12% of baseline, n = 6 cells, 6 spines, p > 0.05; ACSF
versus baclofen, p > 0.05) (Figures 4B and 4C). Together, these
results indicate that in normal (2 mM) extracellular Ca,
GABAB-R activation reduces multivesicular release to lower
synaptic potency. In contrast, in low (1mM) extracellular Ca,mul-
tivesicular release is already reduced andGABAB-R activation no
longer has a presynaptic effect. However, these findings do not
preclude an additional role for GABAB-R modulation of postsyn-
aptic glutamate receptors.
Figure 4. Contributions of Multivesicular
Release
(A) Average time course of probability of release
(left) and average time course of synaptic potency
(right) in 2 mM extracellular Ca and internal
GDP-bS. The running average of the synaptic
potency is shown as a black line. Blue lines indi-
cate average periods in baseline conditions and
baclofen.
(B) Equivalent results as in (A), measured in 1 mM
extracellular Ca and internal GDP-bS.
(C) Summary of changes in probability of release
(left) and synaptic potency (right) following wash-in
of baclofen or ACSF in the different recording
conditions. Asterisks indicate significant (p < 0.05)
difference from 100% or between different
conditions.
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In order to assess postsynaptic GABAB-R modulation, we used
2PLU to bypass the presynaptic terminal and directly activate
glutamate receptors on individual spines (Figure 5A) (Carter
and Sabatini, 2004; Carter et al., 2007; Matsuzaki et al., 2001).
We first isolated 2PLU-evoked NMDA-R Ca signals, recorded
while blocking postsynaptic K channels with intracellular cesium
(Cs), sodium (Na) channels with TTX, and AMPA-Rs with NBQX
(see Experimental Procedures). In neurons held at +10 mV,
these Ca signals had similar amplitudes (0.16 ± 0.02 DG/Gsat,
n = 42) to those evoked by extracellular stimulation, and were
also blocked by 10 mM CPP (2% ± 2% of baseline, n = 3 cells,
5 spines, p < 0.01). We found that 5 mM baclofen strongly sup-
pressed NMDA-R Ca signals (59% ± 6% of baseline, n = 6 cells,
10 spines, p < 0.01; ACSF: 96% ± 8% of baseline, n = 10 cells,
17 spines, p > 0.05; ACSF versus baclofen, p < 0.01) (Figures
5B and 5C). A similar trend was also seen with 1 mM baclofen
(85% ± 12% of baseline, n = 6 cells, 10 spines, p > 0.05; ACSF
versus baclofen, p > 0.05) (Figures 5B and 5C), suggesting that
some of the synaptic potency decrease in our initial two-photon
optical quantal experiments may also be postsynaptic. These
results demonstrate that postsynaptic GABAB-Rs can modulate
NMDA-Rs to suppress spine Ca signals.Neuron 66, 101–1Several additional factors could indi-
rectly contribute to GABAB-R suppression
of 2PLU-evoked NMDA-R Ca signals. For
example, VSCCs have been shown to
influenceNMDA-RCasignals atother syn-
apses (Bloodgood and Sabatini, 2007).
In principle, GABAB-Rs could suppress
NMDA-R Ca signals by inhibiting these
VSCCs (Mintz and Bean, 1993; Scholz
and Miller, 1991). Wash-in of a cocktail of
VSCC blockers (see Experimental Pro-
cedures) effectively blocked Ca signals
evoked by backpropagating action poten-
tials in both dendrites and spines (spine:
8% ± 16% of baseline, dendrite: 4% ±
10% of baseline, n = 3 cells, 5 spine/
dendrite pairs, p < 0.01) (Figure S1, avail-able online). However, these VSCC blockers had no effect on
NMDA-RCasignals (92%±13%ofbaseline, n=5cells, 10spines,
p > 0.05; ACSF: 99% ± 12% of baseline, n = 5 cells, 10 spines,
p > 0.05; ACSF versus baclofen, p > 0.05) (Figure S1). Moreover,
performingexperiments in theseblockersdid not preventmodula-
tionby5mMbaclofen (40%±4%ofbaseline, n=5cells, 10spines,
p < 0.01; ACSF: 84% ± 10% of baseline, n = 5 cells, 10 spines,
p > 0.05; ACSF versus baclofen, p < 0.01) (Figures 6A and 6E).
These results indicate that postsynaptic VSCCs are not required
for GABAB-R modulation of NMDA-R Ca signals.
Postsynaptic GABAB-Rs are usually thought to activate
inwardly rectifying K channels, causing a change in membrane
potential, altering the amount of Mg block of NMDA-Rs, and
thus influencing their Ca signals (Morrisett et al., 1991; Otma-
khova and Lisman, 2004). However, performing experiments in
0 mM extracellular Mg had no impact on modulation by 5 mM
baclofen (65% ± 5% of baseline, n = 5 cells, 10 spines,
p < 0.01; ACSF: 84% ± 6% of baseline, n = 5 cells, 10 spines,
p > 0.05; ACSF versus baclofen, p < 0.05) (Figures 6B and 6E).
These results demonstrate that changes in Mg block cannot
explain the effects on NMDA-R Ca signals.
Release from internal Ca stores can also influence synaptic
NMDA-R Ca signals (Kovalchuk et al., 2000). Consistent with13, April 15, 2010 ª2010 Elsevier Inc. 105
Figure 5. Postsynaptic Modulation of
NMDA-R Ca Signals
(A) (Left) 2PLSM image of dendrite (D) and spine
(S), showing uncaging location (star) and line
scan position (dashed yellow line). (Right) Line
scan through dendrite and spine (top) during
2PLU (arrows), with change in green Ca transient
quantified as DG/Gsat (bottom), in baseline condi-
tions (red) and following wash-in of CPP (black).
(B) Average 2PLU-evoked NMDA-R Ca signals in
baseline conditions (red) and following wash-in
of 1 mM baclofen (left, black) or 5 mM baclofen
(right, black).
(C) Summary of changes in NMDA-R Ca signal
amplitude following wash-in of 5 mM baclofen,
1 mM baclofen, or ACSF. Asterisks indicate signif-
icant (p < 0.05) difference from 100% or between
different conditions.
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GABAB-R Modulation of NMDA-R Ca Signalsthese findings, wash-in of cyclopiazonic acid (CPA) (30 mM),
which depletes internal Ca stores, caused a small but significant
reduction in NMDA-R Ca signals (73% ± 6% of baseline, n = 5
cells, 10 spines, p < 0.05; DMSO: 93% ± 7% of baseline, n = 6
cells, 12 spines, p > 0.05; DMSO versus CPA, p < 0.05) (Figures
6C and 6E). However, performing experiments in CPA did not
prevent modulation by 5 mM baclofen (75% ± 10% of baseline,
n = 5 cells, 10 spines, p < 0.05; ACSF: 100% ± 14% of baseline,
n = 5 cells, 10 spines, p > 0.05; ACSF versus baclofen, p < 0.05)
(Figures 6D and 6E). These results indicate that internal Ca stores
can contribute to NMDA-R Ca signals, but are not required for
GABAB-R modulation. Together, these findings suggest that
postsynaptic GABAB-Rs influence spine Ca signals by directly
modulating NMDA-Rs.
Metabotropic Pathways
GABAB-R activation releases both Gbg subunits that directly
inhibit their targets and Ga i/o subunits that act indirectly via106 Neuron 66, 101–113, April 15, 2010 ª2010 Elsevier Inc.protein kinases (Bettler et al., 2004; Mott
and Lewis, 1994). We next tested for the
involvement of different signaling path-
ways by introducing specific blockers to
either the whole-cell recording pipette
or bathing solution. In the presence of
GDP-bS (3 mM) in the recording pipette,
5 mM baclofen no longer had an impact
on 2PLU-evoked NMDA-R Ca signals
(96% ± 8% of baseline, n = 5 cells,
10 spines, p > 0.05; ACSF: 95% ± 11%
of baseline, n = 5 cells, 10 spines,
p > 0.05; ACSF versus baclofen, p > 0.05)
(Figure 7A). This finding demonstrates
a role for G protein signaling in postsyn-
aptic GABAB-R modulation of NMDA-R
Ca signals.
NMDA-Rs can be modulated by a
variety of protein kinases, including PKA
and protein kinase C (PKC) (Dingledine
et al., 1999; Hollmann and Heinemann,1994). Previous studies indicate that PKA canmodulate Ca influx
throughNMDA-Rs (Skeberdis et al., 2006). Consistent with these
findings, wash-in of the membrane-permeable PKA antagonist
H89 (10 mM) reduced NMDA-R Ca signals (54% ± 5% of base-
line, n = 5 cells, 10 spines, p < 0.01; ACSF: 88% ± 10% of base-
line, n = 5 cells, 10 spines, p > 0.05; ACSF versus H89, p < 0.05)
(Figures 7B and 7F). In the presence of H89 in the bath, 5 mM
baclofen no longer decreased NMDA-R Ca signals relative to
ACSF controls (87% ± 10% of baseline, n = 6 cells, 12 spines,
p > 0.05; ACSF: 86% ± 8% of baseline, n = 6 cells, 12 spines,
p > 0.05; ACSF versus baclofen, p > 0.05), indicating a role for
PKA (Figures 7C and 7F). Similarly, in the presence of the PKA
inhibitory peptide PKI (100 mM) in the recording pipette, 5 mMba-
clofen did not reduce NMDA-R Ca signals relative to ACSF
controls (72% ± 7% of baseline, n = 5 cells, 10 spines, p >
0.05; ACSF: 69% ± 3% of baseline, n = 5 cells, 10 spines, p >
0.05; ACSF versus baclofen, p > 0.05) (Figures 7D and 7F). In
contrast, in the presence of the PKC inhibitory peptide PKC-I
Figure 6. VSCCs, Mg Block, and Internal Ca
Stores Are Not Required for NMDA-RModu-
lation
(A) Average 2PLU-evoked NMDA-R Ca signals in
VSCC blockers (red) and following wash-in of
5 mM baclofen (black).
(B) Average NMDA-R Ca signals in 0 mM Mg (red)
and following wash-in of 5 mM baclofen (black).
(C) Average NMDA-R Ca signals in baseline ACSF
(red) and following wash-in of CPA (black).
(D) Average NMDA-R Ca signals in CPA (red) and
following wash-in of 5 mM baclofen (black).
(E) Summary of changes in NMDA-R Ca signal
amplitude following wash-in of drugs or vehicle
controls in the different recording conditions.
Asterisks indicate significant (p < 0.05) difference
from 100% or between different conditions. See
also Figure S1.
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GABAB-R Modulation of NMDA-R Ca Signals(100 mM) in the recording pipette, 5 mM baclofen continued to
suppress NMDA-RCa signals (44%± 7%of baseline, n = 5 cells,
10 spines, p < 0.01; ACSF: 101% ± 12% of baseline, n = 5 cells,
10 spines, p > 0.05; ACSF versus baclofen, p < 0.01), suggesting
a limited role for PKC (Figures 7E and 7F). These results indicate
that postsynaptic GABAB-Rs modulate NMDA-Rs via the PKA
pathway to influence spine Ca signals.
Previous studies suggest that PKA modulation of NMDA-R Ca
signals may be saturated under baseline conditions (Skeberdis
et al., 2006). Consistent with this, wash-in of the AC activator
forskolin (50 mM) had no effect on our NMDA-R Ca signals
(96% ± 10% of baseline, n = 5 cells, 10 spines, p > 0.05;
DMSO: 91% ± 12% of baseline, n = 5 cells, 9 spines, p > 0.05;
DMSO versus forskolin, p > 0.05) (Figure S2). However, preincu-
bation with 5 mM baclofen in the bath enabled forskolin to
increase NMDA-R Ca signals (128% ± 17% of baseline, n = 7
cells, 14 spines, p < 0.05; DMSO: 97% ± 12% of baseline,Neuron 66, 101–1n = 5 cells, 10 spines, p > 0.05; DMSO
versus forskolin, p < 0.05) (Figure S2).
Thus, forskolin can enhance NMDA-R
Ca signals when constitutive activation
of the PKA pathway is first reduced by
activation of GABAB-Rs.
NoModulation of Synaptic Currents
Postsynaptic modulation of NMDA-Rs
may selectively influence Ca permeability
more than the total synaptic current
(Skeberdis et al., 2006; Sobczyk and
Svoboda, 2007). We used 2PLU to test
whether GABAB-Rs also modulate syn-
aptic currents mediated by AMPA-Rs
and NMDA-Rs. We first isolated AMPA-
R uncaging-evoked EPSCs (uEPSCs),
recorded while blocking postsynaptic K
channels with intracellular Cs, Na chan-
nels with TTX, and NMDA-Rs with CPP
(see Experimental Procedures). AMPA-R
uEPSCs had similar amplitudes andkinetics to those of miniature EPSCs (mEPSCs) recorded in the
same neurons and were blocked by NBQX (10 mM) (0% ± 1%
of baseline, n = 3 cells, 6 spines, p < 0.01) (Figure 8A). Wash-in
of 5 mM baclofen had no effect on AMPA-R uEPSCs
(98% ± 7% of baseline, n = 7 cells, 11 spines, p > 0.05; ACSF:
92% ± 11% of baseline, n = 6 cells, 10 spines, p > 0.05; ACSF
versus baclofen, p > 0.05) (Figure 8B). These results indicate
that GABAB-Rs do not modulate AMPA-Rs, consistent with
previous results in other neurons measuring the effects of
GABAB-Rs on spontaneous EPSCs and mEPSCs (Dittman and
Regehr, 1996; Scanziani et al., 1992).
We next isolated NMDA-R uEPSCs, recorded while blocking
postsynaptic K channels with intracellular Cs, Na channels with
TTX, and AMPA-Rs with NBQX (see Experimental Procedures).
As expected, we could not observe NMDA-R uEPSCs in our
normal recording conditions, because there was no current
at +10 mV. In order to examine NMDA-R uEPSCs, we performed13, April 15, 2010 ª2010 Elsevier Inc. 107
Figure 7. PKA Mediates NMDA-R Modula-
tion
(A) (Left) Average 2PLU-evoked NMDA-R Ca
signals in internal GDP-bS (red) and following
wash-in of 5 mMbaclofen (black). (Right) Summary
of changes in NMDA-R Ca signal amplitude
following wash-in of baclofen or ACSF in GDP-bS.
(B) Average NMDA-R Ca signals in baseline ACSF
(red) and following wash-in of H89 (black).
(C) Average NMDA-R Ca signals in bath-applied
H89 (red) and following wash-in of 5 mM baclofen
(black).
(D) Average NMDA-R Ca signals in internal PKI
(red) and following wash-in of 5 mM baclofen
(black).
(E) Average NMDA-R Ca signals in internal PKC-I
(red) and following wash-in of 5 mM baclofen
(black).
(F) Summary of changes in NMDA-R Ca signal
amplitude following wash-in of drugs or vehicle
controls in the different recording conditions.
Asterisks indicate significant (p < 0.05) difference
from 100% or between different conditions. See
also Figure S2.
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extracellular Mg to remove block. Under these conditions, wash-
in of 5 mM baclofen had no effect on NMDA-R uEPSCs (89% ±
7% of baseline, n = 9 cells, 15 spines, p > 0.05; ACSF: 102% ±
15% of baseline, n = 6 cells, 11 spines, p > 0.05; ACSF versus
baclofen, p > 0.05), but continued to decrease the simulta-
neously recorded NMDA-R Ca signals (66% ± 8% of baseline,
n = 9 cells, 15 spines, p < 0.01; ACSF: 110% ± 14% of baseline,
n = 6 cells, 11 spines, p > 0.05; ACSF versus baclofen, p < 0.01)
(Figure 8C). Similar results were found when recording NMDA-R
uEPSCs and Ca signals in standard 1 mM extracellular Mg at
both 20 mV (uEPSC: 96% ± 14% of baseline, n = 5 cells, 10
spines, p > 0.05; ACSF: 107% ± 16% of baseline, n = 5 cells,
10 spines, p > 0.05; ACSF versus baclofen, p > 0.05; Ca signal:
52% ± 4% of baseline, n = 5 cells, 10 spines, p < 0.05; ACSF:108 Neuron 66, 101–113, April 15, 2010 ª2010 Elsevier Inc.95% ± 12% of baseline, n = 5 cells, 10
spines, p > 0.05; ACSF versus baclofen,
p < 0.05) and +40 mV (uEPSC: 92% ±
12% of baseline, n = 5 cells, 10 spines, p
> 0.05; ACSF: 93% ± 15% of baseline, n
= 5 cells, 10 spines, p > 0.05; ACSF versus
baclofen, p > 0.05; Ca signal: 53% ± 12%
ofbaseline, n = 5 cells, 10 spines, p < 0.05;
ACSF: 97%±14%of baseline, n = 5 cells,
10 spines, p>0.05;ACSFversusbaclofen,
p<0.05) (FigureS3). These results indicate
that GABAB-Rs do not modulate overall
synaptic currents through NMDA-Rs.
Instead, GABAB-R modulation is only
observed when measuring Ca signals
generated in single spines. These findings
are consistent with a decrease in the Ca
permeability of NMDA-Rs due to inhibi-
tion of the PKA pathway (Skeberdiset al., 2006). This selective effect may also explain why this
form of GABAB-R modulation has not previously been detected
in other studies that did not use these optical approaches.
DISCUSSION
We have shown that GABAB-Rs modulate both presynaptic and
postsynaptic targets to influence synaptic transmission at
individual spines. Presynaptic GABAB-Rs indirectly suppress
NMDA-R Ca signals by inhibiting multivesicular release and
reducing the synaptic glutamate signal. Postsynaptic GABAB-
Rs directly suppress NMDA-R Ca signals, without significantly
affecting AMPA-R or NMDA-R synaptic currents. This powerful
form of postsynaptic GABAB-R modulation depends on G pro-
tein signaling and involves the PKA pathway. NMDA-R Ca
Figure 8. No Modulation of AMPA-R or
NMDA-R uEPSCs
(A) (Left) 2PLSM image of dendrite and spine,
showing the uncaging location (star). (Middle)
2PLU (arrow) evokes an AMPA-R uEPSC at
70 mV (red) that is blocked by wash-in of
NBQX (black). (Right) Average AMPA-R uEPSC
(red) is similar to that of the average miniature
EPSC recorded in the same cell (black).
(B) (Left) Average AMPA-R uEPSCs in baseline
conditions (red) and following wash-in of 5 mM
baclofen (black). (Right) Summary of changes in
AMPA-R uEPSC amplitude following wash-in of
baclofen or ACSF.
(C) (Left) Average NMDA-R uEPSCs (top) and Ca
signals (bottom), recorded at 70 mV in 0 mM
extracellular Mg, in baseline conditions (red) and
following wash-in of 5 mM baclofen (black). (Right)
Summary of changes in NMDA-R uEPSC and Ca
signal amplitudes following wash-in of baclofen
or ACSF.
Asterisks indicate significant (p < 0.05) difference
from 100% or between different conditions. See
also Figure S3.
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plasticity, local excitability, and spine morphological changes.
Therefore, their modulation by GABAB-Rs has broad implica-
tions for Ca-dependent function throughout the brain.
Postsynaptic Modulation
The presence of strong presynaptic modulation at many excit-
atory synapses has often made it difficult to study simultaneous
postsynaptic regulation. The classical approach is to measure
the amplitude and time course of quantal events (Dittman and
Regehr, 1996; Scanziani et al., 1992). However, this is usually
only possible for AMPA-Rs, because NMDA-R quantal events
are too small, and spontaneous Ca signals are too infrequent.
Two-photon glutamate uncaging allowed us to bypass theNeuron 66, 101–1presynaptic terminal and directly activate
both AMPA-Rs and NMDA-Rs (Carter
and Sabatini, 2004; Carter et al., 2007;
Matsuzaki et al., 2001). By using
voltage-clamp recordings with intra-
cellular Cs and extracellular TTX, we
were able to isolate synaptic responses
evoked at individual spines. Our results
show that postsynaptic GABAB-R activa-
tion robustly suppresses NMDA-R Ca
signals, independent of any effects on
presynaptic release.
Postsynaptic GABAB-R modulation of
NMDA-R Ca signals is usually thought
to occur through indirect mechanisms.
For example, activation of inwardly recti-
fying K channels can hyperpolarize
the membrane, enhance Mg block of
NMDA-Rs, and reduce their Ca signals
(Morrisett et al., 1991; Otmakhova andLisman, 2004). However, we observed similar GABAB-Rmodula-
tion in recording conditions where (1) neurons were held in
voltage-clamp at different membrane potentials, (2) VSCCs
were blocked, (3) extracellular Mg was reduced to 0 mM, and
(4) internal Ca stores were depleted with CPA. These manipula-
tions reduce any potential indirect effects on NMDA-R Ca
signals, and indicate that modulation is directly onto these
receptors. To our knowledge, this form of postsynaptic
GABAB-R modulation has not previously been shown, likely
because it would be difficult to detect without the combination
of optical tools we have used.
Previous studies have shown that GABAB-Rs inhibit AC and
reduce cAMP levels (Kaupmann et al., 1997; Knight and Bowery,
1996; Wojcik and Neff, 1984). PKA has also been shown to13, April 15, 2010 ª2010 Elsevier Inc. 109
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NMDA-Rs (Greengard et al., 1991; Raman et al., 1996; Skeberdis
et al., 2006). Our results indicate that postsynaptic GABAB-Rs
signal via the PKA pathway to inhibit NMDA-R Ca signals in
dendritic spines. We found that the PKA inhibitors H89 and PKI
both occlude the influence of GABAB-Rs on NMDA-RCa signals,
suggesting that the PKA pathway is necessary. However, while
we rule out a requirement for the PKC pathway in this modula-
tion, we cannot exclude the possibility that Gbg subunits and
other signaling pathways may also play a role.
PKA has a basal level of activity in neurons, such that both
increases and decreases in activity can modulate glutamate
receptors (Raman et al., 1996; Skeberdis et al., 2006). The reduc-
tion of NMDA-R Ca signals with wash-in of H89 likely reflects
block of this steady-state PKA activity. In contrast, the inability
of forskolin to increase these signals suggests maximal PKA
influence in baseline conditions. Thus, prior reduction of PKA
activity with GABAB-R activation allows forskolin to increase
NMDA-R Ca signals. In the PFC, multiple modulators signal via
the PKA pathway, including GABA, dopamine, noradrenaline,
serotonin, and adenosine. In future experiments, it will be inter-
esting to determine the extent to which these modulators
interact to influence Ca signals in dendrites and spines.
In contrast to NMDA-R Ca signals, we observed no influence
of GABAB-R activation on AMPA-R or NMDA-R uEPSCs evoked
at individual spines. The lack of an effect on these postsynaptic
currents suggests that GABAB-Rs selectively modulate the Ca
permeability of NMDA-Rs. This finding is in agreement with the
selective modulation of Ca influx through these receptors by
the PKA pathway (Skeberdis et al., 2006). Because only 10%
of the total NMDA-R current is carried by Ca ions (Garaschuk
et al., 1996; Schneggenburger et al., 1993), this drop in Ca
permeability would be difficult to detect in synaptic currents.
The selective regulation of NMDA-R Ca signals may thus explain
why this form of postsynaptic GABAB-R modulation has not
been previously observed. Finally, these results also suggest
that the effect of GABAB-R activation on extracellularly evoked
AMPA-R and NMDA-R EPSCs mostly reflects presynaptic
modulation of glutamate release and not postsynaptic modula-
tion of these receptors.
Presynaptic Regulation
Previous experiments on GABAB-R modulation of synaptic
transmission have primarily focused on suppression of release,
which occurs at many synapses throughout the brain. Two-
photon optical quantal analysis allowed us to directly measure
successful transmission and assess the impact of GABAB-Rs
on release. This approach has previously been used to examine
presynaptic influences of other modulators in different brain
regions (Higley et al., 2009; Oertner et al., 2002). In our experi-
ments, GABAB-R activation causes a strong drop in Pr, indi-
cating direct modulation of presynaptic transmission. However,
GABAB-R activation also leads to a decrease in synaptic
potency, which could result from either presynaptic or postsyn-
aptic regulation.
Many synapses undergo multivesicular release, which can
lead to graded synaptic responses (Foster et al., 2005; Tong
and Jahr, 1994; Wadiche and Jahr, 2001). Presynaptic inhibition110 Neuron 66, 101–113, April 15, 2010 ª2010 Elsevier Inc.reduces the Pr, causing less multivesicular release, lower
synaptic glutamate concentration, and smaller postsynaptic
responses. At other synapses, this kind of inhibition alone can
explain the modulation of NMDA-R Ca signals (Higley et al.,
2009; Oertner et al., 2002). In our experiments using 2 mM Ca
and GDP-bS, GABAB-R activation reduced both the Pr and
synaptic potency, consistent with reduced multivesicular
release. In support of this conclusion, in our experiments using
1 mM Ca and GDP-bS, in which the multivesicular release was
already reduced, GABAB-R activation reduced only the Pr. These
results suggest that reduced multivesicular release can
contribute to changes in synaptic potency at this synapse,
presumably by lowering the synaptic glutamate concentration
detected by NMDA-Rs.
Relative Contributions
What is the relative contribution of presynaptic and postsynaptic
GABAB-Rs to the modulation of NMDA-R Ca signals? The
answer may depend on the level of ongoing synaptic activity.
For example, presynaptic effects may be prominent when the
Pr is high and multivesicular release is prominent. When Pr falls,
due to short-term plasticity or the influences of othermodulators,
these presynaptic effects may play a smaller role. Similarly,
under physiological conditions, in which Ca in the cortex is closer
to 1 mM (Somjen, 2004), multivesicular release may be less
prominent, and presynaptic effects may be less important.
In contrast, postsynaptic modulation may always influence acti-
vated NMDA-Rs, and therefore consistently inhibit Ca signals in
dendritic spines.
Our experiments indicate differential sensitivity of presynaptic
and postsynaptic modulation to GABAB-R activation. For exam-
ple, we observed prominent presynaptic modulation with 1 mM
baclofen and complete inhibition at 5 mM baclofen. In contrast,
we observed only moderate postsynaptic modulation with
1 mM baclofen, but prominent suppression at 5 mM baclofen.
There are several factors that could produce this difference,
including (1) unique types of GABAB-Rs present at presynaptic
and postsynaptic locations (Pe´rez-Garci et al., 2006; Vigot
et al., 2006), (2) distinct intracellular pathways mediating presyn-
aptic and postsynaptic modulation (Bettler et al., 2004; Mott and
Lewis, 1994), and (3) amplification of presynaptic inhibition by
the power law for neurotransmitter release (Dittman and Regehr,
1996). In future experiments, it will be interesting to test the
related hypothesis that presynaptic modulation may also be
more sensitive to GABA, with postsynaptic modulation requiring
greater levels of inhibitory activity.
Functional Consequences
Throughout the brain, GABAB-R activation controls many
aspects of excitatory synaptic transmission. Presynaptic
GABAB-Rs regulate the probability of neurotransmitter release
and shape the synaptic glutamate signal. Postsynaptic
GABAB-Rs activate inwardly rectifying K channels to generate
a shunting conductance or hyperpolarization. Our results dem-
onstrate that GABAB-Rs also directly modulate postsynaptic
NMDA-R Ca signals in spines. Thus, in addition to modulating
the electrical properties of neurons, GABAB-Rs also have the
capability to influence the biochemical signaling cascades
Neuron
GABAB-R Modulation of NMDA-R Ca Signalsgenerated at synapses. This is an important mechanism by
which GABA signaling helps to control communication between
neurons in the brain.
The modulation of spine Ca signals has widespread implica-
tions for the physiology, development, and disease of neurons
and their circuits. During synaptic activity, NMDA-R Ca signals
reach high concentrations to activate signaling pathways that
trigger diverse neuronal responses (Berridge, 1998; Kennedy,
2000; Zucker, 1999). These Ca signals are particularly important
for synaptic plasticity, including both long-term potentiation and
long-term depression (Collingridge et al., 1983; Cummings et al.,
1996; Dudek and Bear, 1992). They also influence dendrite and
spine excitability by participating in local feedback loops with
other Ca-sensitive ion channels (Bloodgood and Sabatini,
2007). In addition to these physiological effects, NMDA-R Ca
signals play critical roles in morphogenesis (Engert and
Bonhoeffer, 1999; Maletic-Savatic et al., 1999), gene expression
(Bito et al., 1997), and excitotoxicity (Vanhoutte and Bading,
2003). By regulating NMDA-R Ca signals in spines, postsynaptic
GABAB-Rs have the capacity to influence these and other essen-
tial aspects of Ca-dependent neuronal function.
EXPERIMENTAL PROCEDURES
Preparation
Recordings were made from layer 2/3 pyramidal neurons in the medial PFC of
acute slices fromP21–P28C57/BL6mice. Briefly, micewere anesthetized with
a lethal dose of ketamine/xylazine and perfused intracardially with ice-cold
external solution containing (in mM) 65 sucrose, 75 NaCl, 25 NaHCO3,
1.25 NaH2PO4, 25 glucose, 2.5 KCl, 1 CaCl2, 5 MgCl2, 0.4 Na-ascorbate,
and 3 Na-pyruvate, bubbled with 95% O2/5% CO2. Coronal slices (300 mm
thick) were cut in ice-cold external solution and transferred to ACSF containing
(in mM) 119 NaCl, 25 NaHCO3, 1.25 NaH2PO4, 25 glucose, 2.5 KCl, 2 CaCl2,
1 MgCl2, 0.4 Na-ascorbate, and 3 Na-pyruvate, bubbled with 95% O2/5%
CO2. After 30 min in ACSF at 35
C, slices were stored for approximately
30 min at 24C, after which experiments were conducted at 33C–34C.
For experiments in 0 mM extracellular Mg, slices were incubated in ACSF con-
taining NBQX, 2 mM Ca, and 0 mM Mg for 1 hr before recording.
In all experiments, 10 mM D-serine and 10 mM gabazine were present in the
ACSF, to prevent NMDA-R desensitization and block GABAA-Rs, respectively.
In some experiments, one or more of the following drugs were added to the
ACSF (in mM): 10 NBQX, 10 R-CPP, 1 TTX, 1 u-conotoxin-MVIIC, 0.3 SNX-
482, 20 nimodipine, 10 mibefradil, 10 H89, 50 forskolin, 30 CPA, and 1 or 5
R-baclofen. The cocktail of VSCC blockers consisted of u-conotoxin-MVIIC,
SNX-482, nimodipine, and mibefradil. This cocktail blocks Ca signals evoked
by backpropagating action potentials (Figure S1), which are readily observed
in the dendrites of these neurons (Larkum et al., 2007). In extracellular stimu-
lation experiments (Figure 1), R-CPP or NBQXwas added to the bath to isolate
AMPA-R or NMDA-R EPSCs, respectively. All chemicals were from Sigma or
Tocris, with the exception of SNX-482 andu-conotoxin-MVIIC (Peptides Inter-
national, Inc.) and PKC inhibitor peptide (19–36) (PKC-I) (Calbiochem).
Physiology Recordings
Whole-cell recordings were obtained from layer 2/3 pyramidal neurons identi-
fied with IR-DIC at 200–300 mm from the pial surface. Borosilicate recording
pipettes (2–5 MU) were filled with one of two internal solutions. Current-clamp
recordings used (in mM) 135 K-gluconate, 7 KCl, 10 HEPES, 10 Na-phospho-
creatine, 4 Mg2-ATP, and 0.4 NaGTP (290–295 mOsm, pH 7.35 with KOH).
Voltage-clamp recordings used (in mM) 135 Cs-gluconate, 10 HEPES,
10 Na-phosphocreatine, 4 Mg2-ATP, and 0.4 NaGTP (290–295 mOsm, pH
7.35 with CsOH). Solutions also contained Fluo-5F (1000 mM for voltage-
clamp, 200 mM for current-clamp) to monitor Ca levels, and Alexa Fluor 594
(20 mM) to image neuronal morphology. Neurons were filled via the patch elec-trode for at least 15–20 min before imaging. Dye concentrations were chosen
to ensure that Ca signals were in the linear range of the indicators (Carter and
Sabatini, 2004). In some experiments, one of the following drugs were added
to the internal solution (in mM): 3 GDP-bS, 0.1 PKI (6–22), or 0.1 PKC-I (19–36).
Recordings were made using a Multiclamp 700B amplifier, filtered at 5 kHz
for current-clamp recordings and 2 kHz for voltage-clamp recordings, and
sampled at 10 kHz. Action potentials were triggered with brief (2 ms) current
injections (1200–2000 pA) through the recording pipette. Excitatory input fibers
were stimulated with a theta-glass bipolar electrode (tip diameter 1–4 mm) filled
with the extracellular ACSF, using brief (0.2 ms) and small (5–20 mA) current
injections. The electrode was placed approximately 1–5 mm from the spine
of interest, and the spatial resolution of this approach was found to be high.
Two-Photon Microscopy
Intracellular Ca imaging and glutamate uncaging was accomplished with
a custom microscope that combines 2PLSM and 2PLU, as previously
described (Carter and Sabatini, 2004; Carter et al., 2007). For all experiments,
proximal spines in the basal dendrites within a radial distance of 75 mm from
the soma were chosen to reduce voltage-clamp errors.
For 2PLSM, 810 nm light was used to excite Fluo-5F (green) and Alexa Fluor
594 (red), in order to monitor Ca signals and spine morphology, respectively.
Reference frame scans were taken between each acquisition in order to
correct for small spatial drift of the preparation over time. To measure Ca
signals, green and red fluorescence were collected during 500 Hz line scans
across a dendrite-spine or spine-spine pair. Ca signals were quantified as
changes in green fluorescence to red fluorescence (DG/R), normalized to the
maximal green fluorescence to red fluorescence (Gsat/R), giving DG/Gsat
(Bloodgood and Sabatini, 2007). The value of Gsat/R was measured after
each recording using a thin-walled pipette containing a saturating concentra-
tion of Ca (Yasuda et al., 2004), which was positioned directly above the
recorded cell and used at the same recording temperature (33C–34C).
For two-photon optical quantal analysis, cells were voltage-clamped at
+10 mV to relieve Mg block and to inactivate VSCCs (Oertner et al., 2002).
Experiments were performed in the presence of D-serine, gabazine, and
NBQX. Line scans with electrical stimulation were interleaved with line scans
with no stimulation. Line scans were acquired every 15 s for a total of 40 stim-
ulation trials (20 baseline, 20 drug). R-baclofen was washed in for 5 min before
the drug trials. To classify successful trials, the threshold for each spine was
set to two standard deviations of the signal in the line scans with no stimula-
tion. To confirm that small amounts of drift did not result in losing the axon
of interest, two stimuli (50 ms interstimulus interval) were occasionally given
to confirm that the spine was activated. During normal (2 mM) Ca experiments,
spines with Ca signals above the linear range of the indicator were excluded
from analysis. During low (1 mM) Ca experiments, 4 out of 12 spines showed
no synaptic responses after wash-in of 1 mM R-baclofen and were excluded
from the analysis. In Figures 2 and 3, individual DG/Gsat trials are filtered for
display purposes.
For 2PLU, MNI-glutamate was bath applied at 2.5 mM in 6–12 ml of ACSF.
All experiments were performed in the presence of D-serine, gabazine, and
TTX. R-CPP or NBQX was added to isolate AMPA-R or NMDA-R uEPSCs,
respectively. Experiments at 70 mV, 0 mM Mg and 20 mV, 1 mM Mg
were performed in the presence of the VSCC blockers. Glutamate uncaging
was achieved using a 1 ms pulse of 725 nm light. The uncaging location was
chosen at 0.5 mm from the spine head. At this distance, photobleaching and
photodamage are minimal but uEPSCs and Ca signals can be readily obtained
(Carter et al., 2007). The laser intensity was chosen to mimic the amplitude of
spontaneous AMPA-R EPSCs or extracellularly evoked NMDA-R Ca signals.
Similar to experiments using two-photon optical quantal analysis, line scans
were acquired every 15 s for a total of 40 stimulation trials (20 baseline,
20 drug). R-baclofen was washed in for 5 min before the drug trials. Baseline
fluorescencewasmonitored and recordings were discarded if an increase was
detected, which would indicate photodamage.
Data Acquisition and Analysis
Image and physiology data were acquired using National Instruments boards
and custom software written in MATLAB (Mathworks). Off-line analysis was
performed using custom routines written in Igor Pro (Wavemetrics). TheNeuron 66, 101–113, April 15, 2010 ª2010 Elsevier Inc. 111
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around the peak. The amplitudes of NMDA-R Ca signals are averages over
a 150 ms time period, starting 50 ms after the stimulus. In Figures 2, 5, and
8, images of spines and dendrites were treated with a 1.5-pixel-radius
Gaussian filter for display purposes.
Summary data are reported as median ± standard error (SE). The SE was
calculated as the standard deviation of the medians calculated from 10,000
bootstrapped samples from the data. Electrophysiological and imaging data
are shown as the arithmetic mean ± SE from multiple trials of the experiment.
There were occasionally small differences between the mean and median
within a group, which explains some discrepancies between average traces
in figures and medians reported in the text. Most summary data is in box
plot form, showing the median, interquartile range, and 10%–90% range
(whiskers), and including the data from individual experiments (open circles).
Significancewas defined as *p < 0.05 and determined using the nonparametric
Wilcoxon-Mann-Whitney two-sample rank test or the Wilcoxon signed rank
test for paired data (when appropriate), both of which make no assumptions
about the data distribution.
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